This project, in collaboration with Calix, is developing advanced delivery systems to improve the effectiveness of bioactive magnesium oxide (MgO) as a non-antibiotic antimicrobial. By creating formulations that release MgO at the desired location in the gastrointestinal tract, the research aims to enhance its antimicrobial activity, support a healthy gut microbiome, and provide new strategies for reducing reliance on conventional antibiotics in animal health.